1. Home
  2. NRXP vs VATE Comparison

NRXP vs VATE Comparison

Compare NRXP & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

N/A

Current Price

$1.85

Market Cap

54.2M

Sector

Health Care

ML Signal

N/A

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

N/A

Current Price

$4.99

Market Cap

74.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NRXP
VATE
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
54.2M
74.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NRXP
VATE
Price
$1.85
$4.99
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
493.9K
10.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,107,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$847.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$4.05
52 Week High
$3.84
$9.01

Technical Indicators

Market Signals
Indicator
NRXP
VATE
Relative Strength Index (RSI) 47.54 44.56
Support Level $1.65 $4.80
Resistance Level $1.99 $5.37
Average True Range (ATR) 0.10 0.22
MACD 0.01 -0.02
Stochastic Oscillator 53.97 26.38

Price Performance

Historical Comparison
NRXP
VATE

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: